LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. Through these we unite the entire early-stage R&D ecosystem with a shared mission: to accelerate the discovery and development of transformative, life-changing medicines.

Latest News & Commentary

Top 25 of ’25: Discovery & Development eBook

Curated insight from the leaders shaping Drug Discovery and Formulation Delivery

Thought Leadership

Executive Interview with Joshua Baughman, Bristol Myers Squibb

Joshua Baughman Scientific Director, Bristol Myers Squibb

Thought Leadership

Executive Interview with Sam Moorcroft, BioOrbit

Sam Moorcroft Director of Partnerships, BioOrbit

Revolutionary Eye Implant Gives Blind Patients A New lease of Life

Lucia Simmen Senior Digital Content Editor, Oxford Global

Market Insight

How Polyanion Alginate Oligosaccharides Boost LNP Delivery

Philip Rye Chief Scientific Officer, AlgiPharma

D&D LSX - Connect with Peers

Latest Technology Spotlights

The Power of Nanoporous Silicon Dioxide for the Delivery of Large and Small Molecules

A “Function-First” Antibody Discovery Platform for Best-in-Class Therapeutics

Integrated Solutions to Accelerate Drug Discovery

Automation Then And Now – A Strategic Perspective On The Evolution Of Lab Automation Over Two Decades

Latest News

Interview with Paul Workman

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Top 25 of ’25: Discovery & Development eBook

Thought Leadership

Interview with Paul Workman

Paul Workman Professor of Pharmacology and Therapeutics, Institute of Cancer Research

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Rick Ewing Vice President, Head of Chemistry, Rapafusyn Pharmaceuticals

Zoran Rankovic Director, Centre for Chemical Biology & Therapeutics, St. Jude Children’s Research Hospital

Kyle Eastman VP and Head of Chemistry, Halda Therpeutics

Danette Daniels Vice President of the Protein Degrader Platform, Foghorn Therapeutics

Unlocking the Promise of Protein Degraders: Molecular Glues, PROTACs, and the Path Forward

Stefan Schiesser Director Of Medicinal Chemistry, AstraZeneca

Advancing Drug Discovery Ebook Ad

Market Insight: Across R&D Stages

Better Antibodies for Parkinson’s Disease

Insights into Patient Resilience from Antibody Discovery

Targeting TREM2 with Bicyclic Peptides

Understanding The Role Of Microglia In Alzheimer’s Disease

From Genes to Brains: Linking Genetic Risk Factors to Neuronal Dysfunctions in Alzheimer’s Disease

Donor to Donor Variability in Pharmacology: Mole Hill Or Mountain?

Unfolding Precision Medicines Using Phenotypic Screening In Primary Human Cells

AI-Powered Human Brain Organoid Platform To Transform CNS Drug Discovery

LNPs for Cell Type-Specific Gene Targeting in Patient Liver-Derived Fibrosis Organoids

WEE1 Degrader: A New Hope for Solid Tumours

Formulating Proteins For Maximum Stability

FAST Protein-Enabled Proteolipid Vehicles: A Novel Platform For Advanced Gene Therapy Delivery

Peptide ZIP Code Targeting

Co-Delivery and Surface Engineering with Sphingomyelin Nanoparticles

Beyond Short-Acting Peptide With the FluidCrystal Depot